{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:47:23Z","timestamp":1762102043291},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["JP26893012","JP16K19550","JP16H03252"],"award-info":[{"award-number":["JP26893012","JP16K19550","JP16H03252"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development (AMED)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.bbrc.2017.05.109","type":"journal-article","created":{"date-parts":[[2017,5,20]],"date-time":"2017-05-20T08:02:23Z","timestamp":1495267343000},"page":"21-28","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A ubiquitin-proteasome inhibitor bortezomib suppresses the expression of CYP11B2, a key enzyme of aldosterone synthesis"],"prefix":"10.1016","volume":"489","author":[{"given":"Ryo","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadayuki","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.05.109_bib1","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1210\/en.2012-1339","article-title":"Minireview: aldosterone biosynthesis: electrically gated for our protection","volume":"153","author":"Guagliardo","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2017.05.109_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","article-title":"Acute and chronic regulation of aldosterone production","volume":"350","author":"Hattangady","year":"2012","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.bbrc.2017.05.109_bib3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/mend-5-10-1513","article-title":"The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex","volume":"5","author":"Curnow","year":"1991","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2017.05.109_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/cphy.c130050","article-title":"Steroidogenesis-adrenal cell signal transduction","volume":"4","author":"Gallo-Payet","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbrc.2017.05.109_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/me.2003-0005","article-title":"The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production","volume":"18","author":"Bassett","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2017.05.109_bib6","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/en.2009-0977","article-title":"Regulation of aldosterone synthase by activator transcription factor\/cAMP response element-binding protein family members","volume":"151","author":"Nogueira","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2017.05.109_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrendo.2012.230","article-title":"Role of KCNJ5 in familial and sporadic primary aldosteronism","volume":"9","author":"Mulatero","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbrc.2017.05.109_bib8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ajh\/hpu154","article-title":"Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies","volume":"28","author":"Marzano","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbrc.2017.05.109_bib9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A\u00a0double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.bbrc.2017.05.109_bib10","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/CIRCRESAHA.116.303603","article-title":"New approaches in the treatment of hypertension","volume":"116","author":"Oparil","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2017.05.109_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2013.12.004","article-title":"Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells","volume":"383","author":"Matsuda","year":"2014","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.bbrc.2017.05.109_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/gtc.12107","article-title":"TET3-OGT interaction increases the stability and the presence of OGT in chromatin","volume":"19","author":"Ito","year":"2014","journal-title":"Genes cells."},{"key":"10.1016\/j.bbrc.2017.05.109_bib13","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0006-291X(89)80040-3","article-title":"Tissue-specific expression of the human renin gene in transgenic mice","volume":"165","author":"Fukamizu","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.05.109_bib14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0006-291X(05)81180-5","article-title":"Expression of the human angiotensinogen gene in transgenic mice and transfected cells","volume":"180","author":"Takahashi","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.05.109_bib15","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/MCB.02030-07","article-title":"Transrepressive function of TLX requires the histone demethylase LSD1","volume":"28","author":"Yokoyama","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2017.05.109_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A\u00a0simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.bbrc.2017.05.109_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.str.2005.11.019","article-title":"Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome","volume":"14","author":"Groll","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.bbrc.2017.05.109_bib18","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1210\/endo-128-5-2534","article-title":"Regulation of aldosterone synthase cytochrome P-450 in rat adrenals by angiotensin II and potassium","volume":"128","author":"Shibata","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2017.05.109_bib19","doi-asserted-by":"crossref","first-page":"11617","DOI":"10.1016\/S0021-9258(19)50246-0","article-title":"Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes","volume":"268","author":"Fukamizu","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2017.05.109_bib20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature14465","article-title":"Human body epigenome maps reveal noncanonical DNA methylation variation","volume":"523","author":"Schultz","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2017.05.109_bib21","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1530\/JOE-14-0597","article-title":"An update on novel mechanisms of primary aldosteronism","volume":"224","author":"Zennaro","year":"2015","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.bbrc.2017.05.109_bib22","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1182\/blood-2005-11-4541","article-title":"Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma","volume":"107","author":"Miyakoshi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.05.109_bib23","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/HYPERTENSIONAHA.116.08313","article-title":"Hypomethylation of CYP11B2 in aldosterone-producing adenoma","volume":"68","author":"Yoshii","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2017.05.109_bib24","first-page":"5488","article-title":"Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis","volume":"50","author":"Gazdar","year":"1990","journal-title":"Cancer Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17309907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17309907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T19:26:32Z","timestamp":1659036392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17309907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0006291X17309907"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.05.109","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A ubiquitin-proteasome inhibitor bortezomib suppresses the expression of CYP11B2, a key enzyme of aldosterone synthesis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.05.109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}